Twist Bioscience (TWST) COO trades stock via 10b5-1 plan, sells shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Twist Bioscience Corp’s President and COO Patrick John Finn reported option exercises and share sales in a pre-planned trading program. On February 12 and 13, 2026, he exercised multiple stock options for common stock at exercise prices of $23.33 and $26.66 per share, converting them into ordinary shares. Over the same two days, he sold 3,500 and 1,750 shares of common stock in open-market transactions at weighted average prices of about $50.225 and $50.041 per share, with individual sale prices ranging from $50.00 to $50.51. All transactions were executed under a Rule 10b5-1 trading plan adopted on May 13, 2025, and he held 306,250 common shares directly after the reported trades, along with remaining vested stock options.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 5,250 shares ($263,359)
Net Sell
10 txns
Insider
Finn Patrick John
Role
President and COO
Sold
5,250 shs ($263K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 712 | $0.00 | -- |
| Exercise | Stock Option (right to buy) | 500 | $0.00 | -- |
| Exercise | Common Stock | 500 | $23.33 | $12K |
| Exercise | Common Stock | 712 | $26.66 | $19K |
| Sale | Common Stock | 1,750 | $50.041 | $88K |
| Exercise | Stock Option (right to buy) | 1,500 | $0.00 | -- |
| Exercise | Stock Option (right to buy) | 1,000 | $0.00 | -- |
| Exercise | Common Stock | 1,000 | $23.33 | $23K |
| Exercise | Common Stock | 1,500 | $26.66 | $40K |
| Sale | Common Stock | 3,500 | $50.225 | $176K |
Holdings After Transaction:
Stock Option (right to buy) — 32,300 shares (Direct);
Common Stock — 307,288 shares (Direct)
Footnotes (1)
- The transactions reported on this Form 4 were affected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 13, 2025. Represents the weighted average sales price per share. The shares sold at prices ranging from $50.00 to $50.51 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. The option is immediately exercisable. 12/60th of the shares subject to the option vest and become exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. The option is immediately exercisable. 25% of the shares subject to the option vest and become exercisable on October 24, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuing service through each vesting date.
